ALXO ALX ONCOLOGY HOLDINGS INC

BEARISH Impact: 5/10 Institutional Cluster
Horizon weeks Processed 3d 1h ago
Institutional cluster: 6 buyers, 4 sellers (mixed)

Executive Summary

A mixed institutional cluster in ALXO for Q3 2024 shows 6 buyers (net +$124K) and 4 sellers (net -$3.74M), dominated by a massive trim from Marshall Wace (-$3.54M, -74.8% of its position). While D.E. Shaw (+$414K, +1433%) and Verition (+$46K, +308%) doubled down, the aggregate selling pressure far outweighs buying, suggesting institutional de-risking ahead of a catalyst or deteriorating fundamentals.

Key Financial Metrics

Direction
distributing
Buy Value
$1.4M
Sell Value
$3.7M
Net Flow
-$3.6M

Institutional Positions

Net institutional flow: -$3.6M

▲ Buyers (6)

InstitutionActionChangePosition ValueValue Δ
D.E. Shaw DOUBLED +1433.2% $529.0K $414.0K
Verition Fund Management DOUBLED +308.4% $242.0K $46.0K
Walleye Capital DOUBLED +110.3% $420.0K -$241.7K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Marshall Wace TRIM -74.8% $3.8M -$3.5M
Legal & General Group NEAR_EXIT -85.1% $156.0K -$149.1K
Zurcher Kantonalbank NEAR_EXIT -80.9% $39.0K -$37.0K

Actionable Insight

The heavy selling by Marshall Wace and near-exits by three other institutions suggest a loss of confidence. Monitor for upcoming earnings or pipeline catalysts that could reverse sentiment. The small buying by D.E. Shaw and Verition may be speculative bets on a binary event, not a conviction re-rating.

Key Facts

  • 6 buyers added $124K net; 4 sellers reduced $3.74M net — net selling of ~$3.62M
  • Marshall Wace cut 74.8% of its position, selling $3.54M worth of shares
  • D.E. Shaw increased its stake by 1,433% (+$414K), the largest buyer by value
  • Three sellers (Russell, Zurcher Kantonalbank, Legal & General) nearly exited entirely
  • All funds are categorized as asset managers or quant — no activist or family office presence
  • Historical T+20 win rate on ALXO reports is only 25% with avg -4.84% return

Financial Impact

Net institutional selling of approximately $3.62M in Q3 2024, with total selling value of $3.74M versus buying of $124K

institutional ownershipfloat

Risk Factors

  • Marshall Wace's large trim could signal negative non-public information
  • Low historical win rate (25%) on ALXO reports suggests the stock may not follow institutional signals
  • All sellers are asset managers, not distressed or forced sellers — likely deliberate thesis abandonment

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ALXO-2024-Q3
8 reports for ALXO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ALXO — sortable, filterable
Type Now
Jun 12, 2026
3d ago
Institutional Cluster
BEARISH ★ 5/10
$1.52 awaiting T+20awaiting T+20
May 8, 2026
5w ago
8-K
NEUTRAL ★ 5/10
$2.08 $1.54▼ −25.96%▼ −25.98%
May 8, 2026
5w ago
Press Release
BEARISH ★ 6/10
$2.08 $1.54▲ +25.96%▲ +25.98%
May 7, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$1.87 $1.67▼ −10.70%▼ −13.83%
Apr 13, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$1.75 $2.08▲ +18.86%▲ +11.13%
Mar 19, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.19 $1.67▼ −23.74%▼ −31.37%
Feb 28, 2026
15w ago
Institutional Cluster
BULLISH ★ 7/10
$2.12 $1.91▼ −9.91%▼ −1.97%
Feb 27, 2026
15w ago
Press Release
MIXED ★ 6/10
$2.11 $2.04▼ −3.32%▲ +4.24%
Showing 8 of 8

US Market Status

Market Closed — Opens in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access